Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis.
Saved in:
| Title: | Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis. |
|---|---|
| Authors: | Ma, Yuxi1,2,3 (AUTHOR), Li, Yuting1,2,3 (AUTHOR), Lin, Zhenyu1,2,3 (AUTHOR), Wang, Jing1,2,3 (AUTHOR), Hu, Jianli1,2,3 (AUTHOR), Liu, Hongli1,2,3 (AUTHOR), Yang, Yali1,2,3 (AUTHOR), Liu, Junli1,2,3 (AUTHOR) junli78@foxmail.com, Zhang, Tao1,2,3 (AUTHOR) taozhangxh@hust.edu.cn |
| Source: | BMC Cancer. 6/6/2025, Vol. 25 Issue 1, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 185782177 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ma%2C+Yuxi%22">Ma, Yuxi</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Yuting%22">Li, Yuting</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Zhenyu%22">Lin, Zhenyu</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Jing%22">Wang, Jing</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Jianli%22">Hu, Jianli</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Hongli%22">Liu, Hongli</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Yali%22">Yang, Yali</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Junli%22">Liu, Junli</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> junli78@foxmail.com</i><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Tao%22">Zhang, Tao</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> taozhangxh@hust.edu.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 6/6/2025, Vol. 25 Issue 1, p1-9. 9p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=185782177 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-025-14206-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 1 Titles: – TitleFull: Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ma, Yuxi – PersonEntity: Name: NameFull: Li, Yuting – PersonEntity: Name: NameFull: Lin, Zhenyu – PersonEntity: Name: NameFull: Wang, Jing – PersonEntity: Name: NameFull: Hu, Jianli – PersonEntity: Name: NameFull: Liu, Hongli – PersonEntity: Name: NameFull: Yang, Yali – PersonEntity: Name: NameFull: Liu, Junli – PersonEntity: Name: NameFull: Zhang, Tao IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 06 Text: 6/6/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 14712407 Numbering: – Type: volume Value: 25 – Type: issue Value: 1 Titles: – TitleFull: BMC Cancer Type: main |
| ResultId | 1 |